Tepkinly 4 mg/0.8 ml, Konzentrat zur Herstellung einer Injektionslösung
7680691610011
CH-69161
Konzentrat zur Herstellung einer Injektionslösung
Associated product:
TEPKINLY conc inj 4 mg/0.8ml flac 0.8 ml
1 / 3
google
Article details
- Package size
- 1
- Selling units
- 1
- Measure
- Durchstechflasche(n)
- Galenic form
- Konzentrat zur Herstellung einer Injektionslösung
- Galenic group
- unbekannt
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
4.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
21.84 MG | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
0.48 MG | Substance | HBESI |
Authorization holder
AbbVie AG
6330 Cham
Authorization information
- Swissmedic authorization number
- 69161
- Drug name
- Tepkinly 4 mg/0,8 ml, Injektionslösung
- Galenic form
- KOINJ
- ATC Code
- L01FX27
- Authorization status
- B
- Dispensing category
- A
- First authorization
- 15/02/2024
- Authorization expiration date
- 15/02/2026
- IT Number
- 07.16.1.
- Domain
- Human medicine
Package details
- Description (FR)
- TEPKINLY conc inj 4 mg/0.8ml flac 0.8 ml
- Description (DE)
- TEPKINLY Inj Konz 4 mg/0.8ml Durchstf 0.8 ml
- Market launch
- 15/02/2024
- Narcotic (BTM)
- No
Other package sizes (1)
None
1 DUR
GTIN: None